Despite an ongoing Ebola outbreak in the Democratic Republic of Congo, GlaxoSmithKline is giving up efforts to develop three vaccines to combat the virus. It will transfer rights to its work to the Sabin Vaccine Institute in the U.S. 

The Pentagon considers the increasing use of Chinese-made active ingredients in drugs taken by U.S. patients a national security risk, especially as trade tensions between the U.S. and China escalate, Bloomberg reports.

Including inpatient and outpatient environments, hospitals and health systems can expect a 4.57 percent increase in pharmaceutical spending next year, according to Vizient's July 2019 drug price forecast.

Network Health, a health insurer with 120,000 members in Wisconsin, will stop using CVS Caremark as its pharmacy benefit manager Jan. 1, 2020. 

OxyContin maker Purdue Pharma plans to close its manufacturing plant in Durham, N.C., by the end of the year, according to the Stamford Advocate.

With President Donald Trump and Democrats both seeking healthcare policy wins ahead of the 2020 presidential election, Congress will likely pass drug pricing legislation by the end of the year, according to an RBC Capital Markets investors note cited by…

The FDA has approved Turalio, the first therapy for adult patients with a rare, nonmalignant tumor that affects joints and causes severe morbidity.

RWJBarnabas Health System developed a specialized pharmacy team for its intensive care unit that has reduced medication wait times and potential drug errors in critical care settings, according to a new study published in the Journal of Clinical Outcomes.

Patients are increasingly paying more out-of-pocket for their medical care, which is contributing to the rise of consumerism in healthcare. Patients want price transparency when it comes to drug costs but are rarely given it at the point of prescribing.…

A regulatory agency in Colombia has fined Pfizer nearly $25,000 for selling its medications above the maximum prices set by authorities, according to STAT.